Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel protein, readthrough PFDN5-C12orf10
- Molecular classification
- Other (lncRNA/readthrough transcript)
01
Overview
The molecule designated "novel protein, readthrough PFDN5-C12orf10" (ENSG00000288663) is classified as a long non-coding RNA resulting from transcriptional readthrough between the adjacent protein-coding genes PFDN5 and C12orf10 on human chromosome 12[5][1]. It does not code for a protein and lacks functional characterization in the biomedical literature. The annotation reflects a genomic event—readthrough transcription—rather than a discrete molecular entity or validated therapeutic target. The biological significance, if any, has not been experimentally established, and it is not regarded as a target for drug development or as a disease biomarker. Any related functional or therapeutic interest should focus on the canonical genes: *Prefoldin subunit 5* (PFDN5) and *MYG1 Exonuclease* (C12orf10)[5][1].
- Other names
- GC12P053311GC12P053317GC12P053324GC12P053330GC12P053336GC12P053344GC12P053351GC12P053358GC12P053366GC12P053372GC12P053390GC12P053401GC12P053402GC12P053418GC12P053432GC12P053463GC12P053492GC12P053588GC12P059461GC12P060465GC12P061866GC12P065202GC12P069724
02
Biological functions
Other
03
Disease associations
Other
Beyond the preview
Go deeper on Novel protein, readthrough PFDN5-C12orf10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel protein, readthrough PFDN5-C12orf10.